Regulation of chromatin structure is essential for controlling the access of DNA to factors that require association with specific DNA sequences. The ability to alter chromatin organization in a targeted manner would provide a mechanism for directly manipulating DNA-dependent processes and should provide a means to study direct consequences of chromatin structural changes. Here we describe the development and validation of engineered chromatin remodeling proteins (E-ChRPs) for inducing programmable changes in nucleosome positioning by design. We demonstrate that E-ChRPs function both in vivo and in vitro to specifically reposition target nucleosomes and entire nucleosomal arrays, and possess the ability to evict native DNA-binding proteins through their action. E-ChRPs can be designed with a range of targeting modalities, including the SpyCatcher and dCas9 moieties, resulting in high versatility and enabling diverse future applications. Thus, engineered chromatin remodeling proteins represent a simple and robust means to probe regulation of DNA-dependent processes in different chromatin contexts.
Introduction
The nucleosome is the fundamental repeating unit of chromatin, composed of DNA wrapped around an octamer of histone proteins. While nucleosomes are dynamic structures that are constantly assembled, disassembled, and repositioned in the genome, their positions at gene regulatory elements like transcription start sites (TSSs) show characteristic organization (Lai and Pugh, 2017) . Thus, nucleosome positions are thought to have regulatory implications for DNA-dependent processes like transcription, replication and DNA repair (Hauer and Gasser, 2017; MacAlpine and Almouzni, 2013; Venkatesh and Workman, 2015) . Because positions of nucleosomes in the genome play a major role in determining DNA sequence accessibility, the ability to precisely manipulate nucleosome positions would have profound implications for investigating and controlling DNA-dependent processes in vivo.
ATP-dependent chromatin remodeling factors couple the hydrolysis of ATP to the movement of nucleosomes along a fragment of DNA (Cairns et al., 1996; Fazzio and Tsukiyama, 2003; Langst et al., 1999; Smith and Peterson, 2005; Stockdale et al., 2006; Tsukiyama et al., 1994) . By altering the positions of nucleosomes, this family of enzymes controls the accessibility of underlying DNA in vivo, thereby regulating DNA-dependent processes. The CHD and ISWI families of chromatin remodelers contain a conserved catalytic ATPase that drives chromatin remodeling by binding and hydrolyzing ATP (Zhou et al., 2016) , and a C-terminal region that interacts with extranucleosomal DNA to modify the direction and outcome of nucleosome repositioning (Gangaraju and Bartholomew, 2007; Hota et al., 2013; McKnight et al., 2011; Ryan et al., 2011) .
Previous work established that chromatin remodeling by S. cerevisiae Chd1 can be targeted to specific nucleosomes by replacing the native, nonspecific Chd1 DNA binding domain (DBD) with sequencespecific DBDs (McKnight et al., 2011; Nodelman and Bowman, 2013) . We previously showed that hybrid Chd1 fusions with exogenous, sequence-specific DBDs predictably move nucleosomes onto their recruitment sequences in vitro (McKnight et al., 2011) . We recently demonstrated that fusion of Chd1 to the Zn2Cys6 DBD from Ume6, a meiotic repressor from yeast, allows directed nucleosome positioning at target genes across the S. cerevisiae genome (McKnight et al., 2016) .
Here we have simplified and greatly expanded the customizable design and validated the function of sequence-targeted chromatin remodeling proteins using diverse targeting strategies. These engineered chromatin remodeling proteins (E-ChRPs) work with a wide variety of targeting domains and can occlude target DNA sequences by precisely repositioning nucleosomes onto recruitment motifs. We show that E-ChRPs possessing transcription factor (TF) DNA binding domains can block binding of endogenous transcription factors by incorporating TF binding sites into nucleosomes genome-wide. E-ChRPs can also be directly recruited to DNA-associated TFs through SpyTag/SpyCatcher pairs (Zakeri et al., 2012) allowing for identification and occlusion of TF-bound genomic loci. Finally, we show that positioning of nucleosomes can be achieved by a dCas9-targeted E-ChRP using optimized, noncanonical gRNAs.
Design
The core E-ChRP design was inspired by previous work (McKnight et al., 2011; McKnight et al., 2016) where individual sequence-specific DNA binding domains (DBDs) replaced the C-terminal nonspecific DNA binding domain of a functional S. cerevisiae Chd1 chromatin remodeler fragment ( Fig 1A) . Yeast Chd1 is an ideal enzyme for engineered chromatin remodeling because it is monomeric, displays robust nucleosome positioning activity on nucleosome substrates derived from multiple organisms, and is less influenced by histone modifications than other chromatin remodelers (Ferreira et al., 2007; Hauk et al., 2010) . After the Chd1 catalytic module we incorporated unique restriction sites flanking the targeting domain in vectors allowing for recombinant expression in E. coli, constitutive expression from ADH1 or GPD promoters in S. cerevisiae (Mumberg et al., 1995) , or galactose-inducible expression from the HO locus in S. cerevisiae (Voth et al., 2001) . This scaffold allows easy swapping of the C-terminal targeting domain resulting in a simple method to design chromatin remodelers that can be localized to desired nucleosomes. To demonstrate the versatility of the approach, we incorporated and assessed engineered chromatin remodeling through multiple transcription factor DNA binding domains, through SpyCatcher/SpyTag pairs, and through dCas9 targeting ( Fig 1B) . We first assessed the ability of different E-ChRPs to reposition target-containing mononucleosomes in a purified biochemical assay (Eberharter et al., 2004) . To validate in vivo function, we introduced E-ChRPs into S. cerevisiae and measured global nucleosome positions by MNase-seq. Functional E-ChRPs can position targeted nucleosomes onto recruitment motifs as measured by mononucleosome sliding toward recruitment sequences in vitro or target motif occlusion by nucleosomes in vivo ( Fig 1C) .
Development and Optimization of a Targeted Remodeler Core
We previously demonstrated that fusion of a foreign DNA binding domain to the Chd1 catalytic core leads to occlusion of a recruitment motif by targeted and directional repositioning of nucleosomes (McKnight et al., 2011; McKnight et al., 2016) . Though functional both in vitro and in vivo, remodeler fusions where the DNA binding domain was directly fused to the Chd1 core resulted in a limited "reach" and nucleosomes residing further than 20 base pairs from the DNA recognition element were not efficiently moved. In addition, the creation of new remodeler fusion proteins was previously cumbersome and lacked versatility. To address these limitations we first created the E-ChRP scaffold ( Fig   1A) , which consists of the catalytic core of the yeast Chd1 protein followed by a flexible linker including 11 repeats of the glycine-glycine-serine sequence that was previously shown to extend the Chd1 reach (Nodelman and Bowman, 2013) . We next created an array of plasmids for recombinant bacterial expression or yeast constitutive or inducible expression allowing for one-step cloning of a desired fusion domain ( Fig 1A) .
We examined whether the addition of a flexible linker between the Chd1 remodeler core and DNA binding domain increased the reach of these E-ChRPs. We tested the ability of an E-ChRP with a DBD from the S. cerevisiae meiotic repressor Ume6 to move mononucleosomes containing a recognition motif, URS1 (Park et al., 1992) , 20 or 40 base pairs from the nucleosome edge (Fig 2A) . Without a flexible linker, the Chd1-Ume6 E-ChRP was active exclusively when the motif was 20bp away (compare lanes 1 with 3, 2 with 4). In contrast, addition of eleven repeats of glycine-glycine-serine (GGSx11) allowed the remodeler to efficiently mobilize both nucleosome substrates (compare lanes 1 with 5, 2 with 6). Additionally, the final location of the positioned nucleosomes was dependent on the location of the recognition motif (Fig 2A, compare lanes 5 and 6). Consistent with this increased reach in vitro, the Ume6 E-ChRP containing a GGSx11 linker positioned a larger fraction of distal nucleosomes onto target sequences across the S. cerevisiae genome ( Fig 2B, C) . Because the flexible linker led to more robust E-ChRP activity and our design was compatible in vitro and in vivo, we employed this general scaffold in all subsequent experiments.
Remodeler Fusions are Highly Versatile in vitro and in vivo
We next tested mononucleosome targeting of multiple E-ChRPs with various DNA binding domains. We fused the DBD from E. coli AraC, S. pombe Res1, D. melanogaster Engrailed, or R. norvegicus Glucocorticoid Receptor to the E-ChRP scaffold. To determine if these E-ChRPs were functional on target nucleosomes in vitro, we generated end-positioned mononucleosomes assembled on the 601positioning sequence (Lowary and Widom, 1998) with 125 base pairs of flanking DNA. The extranucleosomal DNA either contained or lacked a consensus binding motif corresponding to each different fusion tested. E-ChRPs containing DNA binding domains were able to mobilize nucleosomes containing their well-defined recruitment motifs (Ades and Sauer, 1994; Alroy and Freedman, 1992; Ayte et al., 1995; Niland et al., 1996) as measured by a native PAGE nucleosome sliding assay ( Fig 3A) .
These E-ChRPs were inactive on nucleosomes lacking their respective motifs (Fig. 3A, lanes 22-27) , demonstrating specificity for target substrates in vitro. Fusion of the native, sequence-nonspecific DBD from Chd1 to our E-ChRP scaffold showed no apparent discrimination against DNA sequences and was capable of fully mobilizing the nonspecific mononucleosome control (Fig. 3A , lanes 28-30).
To determine whether E-ChRPs can be differentially targeted to specific subsets of nucleosomes in vivo,
we introduced E-ChRPs into S. cerevisiae on a constitutive, ADH1-driven expression plasmid. When the E-ChRP contained a Ume6 DNA binding domain, nucleosomes were repositioned toward Ume6 binding motifs across the genome, but no nucleosome changes were detected at other genomic loci. Similarly, an E-ChRP containing the Engrailed DNA binding domain moved nucleosomes onto Engrailed motifs in the yeast genome without altering nucleosome positions at Ume6 binding motifs ( Fig 3B) . We also introduced Ume6 and Engrailed E-ChRPs into yeast under the high-expression GPD (TDH3) promoter on a 2μm plasmid (Mumberg et al., 1995) . Expression of the Ume6 E-ChRP from this construct resulted in positioned nucleosomes at target sites without identified off-target activity similar to an ADH1-driven E-ChRP ( Fig S1A) . However, introduction of this higher expression plasmid containing an Engrailed E-ChRP only produced viable transformants in which the E-ChRP construct was deleted, truncated or mutated.
This obligate inactivation of the Engrailed E-ChRP at high expression levels may result from promiscuous action of the Engrailed E-ChRP at tens of thousands of potential target sequences, which would presumably disrupt global nucleosome positioning in a deleterious and pleiotropic manner. Importantly, even when driven from the GPD (TDH3) promoter neither the Ume6 E-ChRP nor the Engrailed E-ChRP was active at target sites when the Chd1 remodeler core contained a catalytically-inactive Walker B (D513N) substitution (Hauk et al., 2010; Walker et al., 1982) (Fig S1A,B ). Taken together, these results suggest that E-ChRPs can be specifically targeted through multiple distinct DNA binding domains that recognize sequence motifs with high or low complexity both in vitro and in vivo.
E-ChRPs can Inducibly Remove Transcription Factors
To gain temporal control of E-ChRPs in vivo, we introduced the Ume6 E-ChRP under the control of a galactose-inducible promoter integrated at the HO locus in yeast (Voth et al., 2001) . Prior to addition of galactose, endogenous Ume6 associates with its consensus sequence across the genome and cooperates with the ISW2 complex to position motif-proximal nucleosomes, leaving 30 bp between the nucleosome edge and URS1 motif (Goldmark et al., 2000; McKnight et al., 2016) . After galactose induction of the Ume6 E-ChRP, a majority of nucleosomes nearest the URS1 site are efficiently repositioned to occlude the URS1 motif within two hours ( Fig 4A) . This galactose-inducible approach allows for more complete remodeling of nucleosomes than the same E-ChRP under the control of a constitutively active ADH1 promoter, potentially commensurate with differing expression levels under these distinct promoters ( Fig 4A) .
We reasoned that because the post-induction nucleosome position results in the Ume6 recruitment motif becoming buried within nucleosomal DNA, remodeling by the Ume6 E-ChRP should interfere with binding of endogenous Ume6 ( Fig 4B) . To test this possibility, we tagged endogenous Ume6 with a FLAG epitope and measured Ume6-FLAG binding by ChIP-seq before and after induction of the Ume6 E-ChRP.
Prior to induction, reproducible Ume6-FLAG binding was observed at URS1 sites across the genome ( Fig   S2A) . After induction of the Ume6 E-ChRP, which shifted nucleosomes over URS1 sites, Ume6 binding (as measured by Ume6-FLAG ChIP signal) was strongly reduced or eliminated at many genomic locations ( Fig S2A,B ). When we sorted Ume6 binding sites based on whether proximal nucleosome positions were shifted after Ume6 E-ChRP induction, we noticed that loss of Ume6-FLAG signal was strikingly reduced where nucleosomes were shifted, but minimally reduced where nucleosomes were not shifted ( Fig 4C,   S2B ). To verify that this reduction in Ume6-FLAG signal was not due to direct binding competition between endogenous Ume6-FLAG and the E-ChRP Ume6 DNA binding domain, we measured Ume6-FLAG ChIP signal in the presence of a catalytically inactive Ume6 E-ChRP. This construct, which cannot move nucleosomes but retains the Ume6 DNA binding domain, did not similarly reduce Ume6-FLAG signal ( Fig S2A,B) . Thus, E-ChRPs can inducibly move nucleosomes over target sequences to restrict access of the underlying DNA to endogenous DNA binding factors.
SpyCatcher E-ChRPs Allow Simple Targeting to Chromatin-Bound Loci
One limitation of the above-described E-ChRPs is their need to compete with endogenous factors for binding sites. To circumvent this problem, we created an E-ChRP where the SpyCatcher protein is fused in place of a DNA binding domain in the Chd1 E-ChRP scaffold. SpyCatcher specifically recognizes a short (~1kDa) SpyTag epitope, forming an isopeptide linkage that allows covalent protein fusions to be created in vitro and in vivo (Zakeri et al., 2012) . This fusion provides two major improvements to the E-ChRP system. First, by simply appending SpyTag to different chromatin-binding factors of interest, nucleosome positioning can be achieved by a single SpyCatcher E-ChRP without the need to design new DBD fusions ( Fig 5) . Second, by tagging a transcription factor at its endogenous locus, the protein becomes a targetable element for the SpyCatcher E-ChRP only when bound to chromatin ( Fig 5A) . This bypasses the requirement of a vacant DNA binding site to target a DBD-containing E-ChRP, allowing access to sequences in the genome that could otherwise be blocked by a stably-bound transcription factor. In sum, this strategy produces a single SpyCatcher E-ChRP that can be targeted to any chromatinbound protein of interest in the genome by simple attachment of a short SpyTag.
To validate the function of the SpyCatcher E-ChRP design, we purified recombinantly-expressed Chd1- repositioning of mononucleosomes in vitro, demonstrating the versatility of this system. We next introduced the SpyCatcher E-ChRP under a constitutive ADH1 promoter into S. cerevisiae cells where a C-terminal SpyTag was added to full-length Ume6 at the endogenous locus. As expected, we observed repositioned nucleosomes at URS1 sites across the genome indicating chromatin remodeling at Ume6bound loci ( Fig 5C) .
To achieve temporal control of this modular system in vivo, we appended SpyTag to the C-terminus of either Ume6 or Reb1, a yeast general regulatory factor, in a strain harboring a galactose-inducible SpyCatcher E-ChRP at the HO locus. After induction of SpyCatcher E-ChRP expression, nucleosomes were shifted toward Ume6 binding sites in cells containing Ume6-SpyTag or toward Reb1 binding sites in cells containing Reb1-SpyTag ( Fig 5D, Fig S3A,B) . Interestingly, the fraction of shifted nucleosomes was generally low at Ume6 binding sites in Ume6-SpyTag cells but comparatively higher at Reb1 binding sites in Reb1-SpyTag strains ( Fig 5D) . This difference could be explained by higher occupancy or stability of Reb1 than Ume6 binding at target sites, which would allow a greater fraction of Reb1-tethered SpyCatcher to mobilize motif-proximal nucleosomes. Consistent with this possibility, the cellular abundance of Ume6 is significantly lower than that of Reb1 (Kulak et al., 2014) . For Reb1-SpyTag strains, the positioning of a single motif-proximal nucleosome by the SpyCatcher E-ChRP initiated the shift of an entire array of nucleosomes toward the target motif ( Fig S3C) , consistent with previous observations that the positioning of a "barrier nucleosome" influences and constrains positions of an entire array of nucleosomes (Mavrich et al., 2008; McKnight et al., 2016) .
Interestingly, the positioning of nucleosomes appeared to occur on only the 5' side of the Reb1 recognition sequence, suggesting the orientation of Reb1 binding impacts the ability of Chd1 to reach nucleosomes near binding sites ( Fig 5D, Fig S3C) . This restriction could be explained by a constrained Cterminus of Reb1 when bound to chromatin, which is consistent with similarly constrained Reb1-MNase cleavage patterns seen in previous ChEC-seq experiments (Zentner et al., 2015) . Unexpectedly, the fraction of nucleosomes shifted at individual Reb1 binding sites varied greatly in our data set, with some sites exhibiting repositioning of nearly 100% of motif-proximal nucleosomes in the population and others having a much smaller fraction moved ( Fig 6A-C) . These differences are not explained by initial nucleosome occupancy or location differences ( Fig 6B) , but are possibly related to relative Reb1 occupancy at different genomic locations.
To better validate the ability of SpyCatcher E-ChRP to identify fractional Reb1 occupancy at Reb1 binding sites, we compared our data set to crosslinking ChIP, CUT&RUN (Skene and Henikoff, 2017) , ORGANIC (Kasinathan et al., 2014) and ChEC-Seq (Zentner et al., 2015) data sets. There was striking correlation between our data, ORGANIC and ChEC-Seq, with some motifs exclusively showing Reb1 occupancy when measured by these three methods ( Fig S4) . Relative Reb1 occupancies mapped by CUT&RUN and standard ChIP were less correlated with our data, suggesting that formaldehyde-free binding profiles similarly capture relative TF occupancy. Minimally, the observation that all nucleosomes are shifted at some Reb1 binding sites in a population of cells argues that some Reb1 sites are nearly 100% occupied, as E-ChRP-derived nucleosome movement cannot be observed without Reb1 binding ( Fig 6C) . While these Reb1 occupancy estimates are conflated with presence, accessibility and relative occupancy of motif-proximal nucleosomes, our data suggest that SpyCatcher E-ChRPs can serve as a relative measure of protein localization in cells that is orthogonal to ChIP, allowing for a lower-limit estimate of SpyTagged protein occupancy at individual binding motifs in the genome.
dCas9-targeted Nucleosome Positioning with Nonstandard gRNAs
While the E-ChRPs described above show robust nucleosome positioning activity when targeted through various DNA binding domains or through SpyCatcher/SpyTag pairs, their ability to alter nucleosome positions depends on the interaction between pre-existing DNA binding domains with defined DNA motifs. To overcome this limitation and allow targeted positioning of single nucleosomes by design, we created a dCas9 E-ChRP (Fig 7) . This construct allows versatile targeting to specific nucleosomes by designing proximal gRNAs. We recombinantly expressed the dCas9 E-ChRP in E. coli and purified the ~300kDa fusion protein. To test its ability to move gRNA-targeted nucleosomes we reconstituted endpositioned mononucleosomes and designed gRNAs with or without complementarity to the extranucleosomal DNA. Successful gRNA-stimulated chromatin remodeling would result in movement of the nucleosome toward the target sequence, producing a slower-migrating centrally-positioned nucleosome ( Fig 7A) . While nucleosomes were efficiently moved toward the center of DNA fragments with control Chd1 protein, introduction of Chd1-dCas9 and complementary gRNA resulted in supershifted complexes with unresolved nucleosome positions. Even in the presence of 1000-fold competitor DNA for 3 days, the Chd1-dCas9 fusion protein would not release from gRNA-targeted nucleosomes ( Fig 7B) . This inability of dCas9 to release from target sequences is consistent with the ability of dCas9 to specifically bind and interfere with transcription in cells due to stable R-loop formation (Jinek et al., 2012; Laughery et al., 2019; Qi et al., 2013) . Importantly, the inability of the dCas9 E-ChRP to release from substrate prevents its utility for precise, gRNA-targeted nucleosome positioning.
To promote release of the dCas9 E-ChRP from nucleosome substrates, we used gRNAs with noncanonical structures (Fig 7C) including a truncated gRNA (Fu et al., 2014) containing only 14nt of complementarity to target sequences, a gRNA with a PAM-distal hairpin (Josephs et al., 2015) that has predicted self-annealing capacity and reduced affinity for target sequences, and a 20nt gRNA with a PAM-distal 3nt-mismatch (mm-gRNA) that would result in an R-loop with a frayed end. Both the tru-gRNA and the mm-gRNA allowed for efficient targeted repositioning of nucleosomes toward the gRNA binding site either through direct Chd1-dCas9 fusion or introduction of Chd1-SpyCatcher and dCas9-SpyTag pairs ( Fig 7D, lanes 1-10 and Fig S5) . These noncanonical gRNAs promoted multi-turnover catalysis by the dCas9 E-ChRP demonstrating that the weakened dCas9/gRNA complexes were stable enough to promote specific enzymatic activity but weak enough to readily and repeatedly disengage from its substrate ( Fig 7D, lanes 11-20) . Strikingly, dCas9-Chd1 targeted through weakened gRNAs did not require any competitor DNA to disengage from nucleosome substrates ( Fig 7E) . We believe this ability to readily dissociate from DNA targets while providing enough dwell time and specificity for targeted nucleosome positioning provides a facile method to alter nucleosome positions by design.
Furthermore, readily-dissociating mm-gRNAs can likely be employed for dCas9-targeted epigenome editing in cells, since current epigenome editing with canonical gRNAs likely leads to a combination of local epigenetic modification and stably-bound, mutagenic R-loop formation from strong dCas9 binding (Laughery et al., 2019) .
Discussion
In conclusion, we have created and validated the use of E-ChRPs as an easy and versatile method for altering the positions of specific nucleosomes both in vitro and in vivo. We have demonstrated that E-ChRPs have widespread compatibility with various DNA binding domains and have created a single SpyCatcher E-ChRP that can be inducibly attached to chromatin-associated factors to move adjacent nucleosomes. We have shown that induced positioning of nucleosomes by E-ChRPs can establish new nucleosomal arrays, occlude transcription factor binding motifs across the genome, and report on relative transcription factor occupancy at target motifs. Finally, we have optimized a dCas9-targeted E-ChRP by creating weakened, noncanonical guide RNAs with PAM-distal mismatches to robustly position and release from targeted nucleosomes in vitro.
We envision future research can employ E-ChRPs to probe questions directly relating the position of nucleosomes to downstream biological processes and can lead to insight into how cells can tolerate or correct ectopic nucleosome positioning events. We further expect weakened gRNAs will be an effective strategy to target specific epigenetic changes or nucleosome positioning changes in cells while limiting indirect consequences of stably-or irreversibly-bound dCas9 (Laughery et al., 2019) . Finally, the ability to position nucleosomes onto target sequences may potentially lead to the development of E-ChRPs that block oncogenic or other disease-related transcription factors from accessing binding sites genomewide.
Limitations
While the E-ChRPs described in this work are highly versatile allowing for multiple targeting schemes, there are some limitations in the ability of E-ChRPs to position target nucleosomes. First, to create a functional Chd1-TF(DBD) fusion, the boundary of the DNA binding domain for the specific transcription factor must be known, and it must fold in the context of the fusion protein. While all fusions we have tested have been functional to date, we focused on well-behaved and well-studied DNA binding domains. Second, there is still a limitation on how far E-ChRPs can "reach". Based on our in vivo mapping results, if a nucleosome edge is initially beyond ~75 base pairs from the E-ChRP recruitment site, nucleosome repositioning activity is less favorable. Moreover, E-ChRPs do not appear to have any de novo nucleosome deposition activity, so exaggerated nucleosome-free regions of the genome would not permit nucleosome positioning. While we are very interested in the ability of SpyCatcher E-ChRPs to position different fractions of nucleosomes at different sites in the genome and we speculate this is due to relative SpyTagged TF occupancy, our method is blind to TF binding sites where there are no motifproximal nucleosomes. Further, it would be challenging to use E-ChRPs in isolation to define TF binding landscape due to the relatively noisy signal generated from fractional repositioned nucleosomes. This is especially true for sites where small fractions of nucleosomes are repositioned. Finally, while the determination that dCas9 E-ChRPs work readily with mismatched gRNAs may allow better assessment of targeted chromatin modification effects (since dCas9 does not remain stably associated with the target sequence), we note that mismatched gRNAs naturally possess a lower capacity for target specificity.
Nevertheless, the robust activity we see with dCas9 E-ChRPs and mismatched gRNAs may be generally useful for assessing metastable off-target locations of gRNAs.
Methods

Plasmids, Strains, and Growth Conditions
The initial Ume6 E-ChRP scaffold was prepared by Gibson assembly (Gibson et al., 2009 ) in p416-ADH1 (Mumberg et al., 1995) to include an N-terminal NLS (KKKRK), residues 118-1000 of S. cerevisiae Chd1, nine repeats of glycine-glycine-serine, residues 1001-1014 of S. cerevisiae Chd1, two additional repeats of glycine-glycine-serine, an AfeI restriction site, residues 764-836 from S. cerevisiae Ume6 and a HindIII restriction site. An analogous backbone was also created with residues 118-1000 of S. cerevisiae Chd1 linked directly to the two glycine-glycine-serine repeats followed by AfeI, Ume6 DBD, and HindIII site.
Cloning vectors were created in pDEST17, p416-TEF, p416-GPD, p426-GPD and HO-pGAL-poly-KanMX4-HO (Voth et al., 2001 ) (a gift from David Stillman, Addgene 51664) to swap the C-terminal Ume6 domain with other targeting domains using AfeI/HindIII restriction cloning, sticky-end PCR or Gibson Assembly (Gibson et al., 2009; Walker et al., 2008) . Fusions used in this study include S. cerevisiae Ume6 (residues 764-836, cloned from yeast genomic DNA), D. melanogaster Engrailed (residues 454-543, cloned from fly genomic DNA), S. pombe Res1 (residues 1-147, cloned from a gBlock), R. norvegicus Glucocorticoid Receptor (residues 428-513, cloned from a gBlock), E. coli AraC (residues 175-281, provided by Gregory Bowman), the SpyCatcher domain (Zakeri et al., 2012 ) (a gift from Mark Howarth, Addgene 35044) and dCas9 (subcloned from Addgene 49013, a gift from Timothy Lu (Farzadfard et al., 2013) ). Non-integrating plasmids (p416-or p426-) were transformed into S. cerevisiae strain W303 (RAD5+) and grown in SD -Ura overnight, diluted to OD600=0.2 in SD -Ura and grown to OD600=0.6-0.8 for chromatin analysis. For galactose induction of E-ChRPs, cells were grown in YP media with 2% raffinose as the sole carbon source. In mid-log phase, raffinose (-induction) or galactose (+ induction) was added to a final concentration of 2% and cells were grown for 2 additional hours at 30 o C with shaking. Cells were then fixed and harvested for chromatin analysis. To make SpyTagged yeast strains, a C-terminal 3x-FLAG tag followed by the SpyTag sequence (AHIVMVDAYKPTK) was added by integration at the endogenous locus for the protein of interest using a selectable drug marker. To recombinantly express SpyTagged DNA binding domains for biochemical analysis, domains of interest were amplified by PCR from source (yeast or fly genomic DNA) followed by restriction cloning into a pDEST-MCS-SpyTag vector.
Protein Purification
Chd1 constructs were expressed from pDEST17 vectors (Invitrogen) as previously described (Hauk et al., 2010) . Briefly, proteins were expressed in BL21(DE3) cells, with the RIL plasmid (Stratagene) to aid expression and a plasmid expressing the Trigger Factor chaperone (a kind gift from Li Ma and Guy Montelione) to improve solubility. After induction with 300uM isopropyl-D-thiogalactopyranoside (IPTG) and growth at 18°C for 16 h, cells were lysed by sonication in 500 mM NaCl, 10% glycerol, and 25 mM Tris, pH 7.8. Lysate was clarified by centrifugation at 25,000xg and soluble protein was purified using Co 2+ affinity chromatography (TALON column, GE Healthcare) followed by anion-exchange chromatography (Q-FF, GE Healthcare).
Nucleosome Sliding Assay
Recombinant yeast histones were purified as previously described (Luger et al., 1999) and dialyzed by gradient salt dialysis onto the Widom 601 positioning sequence (Lowary and Widom, 1998) concentration. For Chd1-SpyCatcher-SpyTag-dCas9 reactions ( Figure S5 ), 10-fold excess, concentrated Chd1-SpyCatcher was pre-incubated with SpyTag-dCas9 for 1 hour prior to dilution and reaction initiation.
Micrococcal Nuclease Digestions and Library Construction
Micrococcal nuclease digestions were performed as previously described (Rodriguez et al., 2014) .
Briefly, cells were grown to mid-log phase and fixed with 1% formaldehyde. Chromatin was digested with 10, 20, and 40 units of MNase for 10 minutes. Proper nuclease digestion of DNA was analyzed by agarose gel and samples with approximately 80% mononucleosomes were selected for library construction. After crosslink reversal, RNase treatment, Calf Intestine Phosphatase (CIP, NEB) treatment and Proteinase K digestion, mononucleosome-sized fragments were gel-purified and used to construct libraries with the NuGEN Ovation Ultralow kit per the manufacturer's instructions. Libraries were sequenced at the University of Oregon's Genomics and Cell Characterization Core Facility on an Illumina NextSeq 500 on the 37 cycle, paired-end, High Output setting, yielding approximately 20 million paired reads per sample.
Chromatin Immunoprecipitation and Library Construction
Chromatin immunoprecipitation was performed as previously described (Rodriguez et al., 2014) . Briefly, cells were grown to mid-log phase, fixed with 1% formaldehyde, and lysed by bead-beating in the presence of protease inhibitors. Chromatin was fragmented by shearing in a Bioruptor sonicator (Diagenode) for a total of 30 minutes (high output, 3x10' cycles of 30 sec. on, 30 sec. off). Sonication conditions were optimized to produce an average fragment size of ~300 basepairs. FLAG-tagged protein was immunoprecipitated using FLAG antibody (Sigma) and Protein G magnetic beads (Invitrogen). After crosslink reversal and Proteinase K digestion, DNA was purified using Qiagen MinElute columns and quantified by Qubit High-Sensitivity fluorometric assay. Libraries were prepared using the NuGEN Ovation Ultralow kit by the manufacturer's instructions and sequenced at the University of Oregon's Genomics and Cell Characterization Core Facility on an Illumina HiSeq4000 with 50 or 100 cycles of single-end setting, yielding approximately 15 million reads per sample.
Data Processing and Analysis
MNase sequencing data were analyzed as described previously McKnight et al., 2016) . Briefly, paired-end reads were aligned to the S. cerevisiae reference genome (Cunningham et al., 2015) with Bowtie 2 (Langmead and Salzberg, 2012) , and filtered computationally for unique fragments between 100 and 200 bp. Dyad positions were calculated as the midpoint of paired reads, then dyad coverage was normalized across the S. cerevisiae genome for an average read/bp of 1.0. Nucleosome alignments to transcription factor binding sites were performed by taking average dyad signal at each position relative to all intergenic instances of a motif center. Motifs were obtained from the JASPAR database (Khan et al., 2018) and intergenic instances were found using the Saccharomyces Genome Database Pattern Matching tool (http://www.yeastgenome.org/cgibin/PATMATCH/nph-patmatch). Specifically, the Reb1 motif was defined as TTACCC(G/T) and Ume6 motif was WNGGCGGCWW. For ChIP-seq data, single-end reads were aligned to the S. cerevisiae reference genome with Bowtie 2 and total read coverage was normalized such that the average read at a genomic location was 1.0. ChIP peaks were called using a 400 bp sliding window with a threshold average enrichment within the window of 4.0. Reb1 ORGANIC data (Kasinathan et al., 2014) were from the "80mM IP" sample (SRX263794) ; Reb1 CUT&RUN data (Skene and Henikoff, 2017) were from merged "cut-and-run 8s" and "cut-and-run 16s" samples (SRX2009989 and SRX2009990) ; Reb1 ChECseq data (Zentner et al., 2015) were from the "Reb1 ChEC-seq 30s" (SRX974362). Data were visualized using Integrated Genome Browser (Freese et al., 2016) . for the respective E-ChRP (Ades and Sauer, 1994; Alroy and Freedman, 1992; Anderson et al., 1995; Ayte et al., 1995; Khan et al., 2018; Niland et al., 1996) (See also Figure S1 ) 
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